IL106462A - Phenylimidazolidine derivatives their preparation and pharmaceutical compositions containing them - Google Patents
Phenylimidazolidine derivatives their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL106462A IL106462A IL10646293A IL10646293A IL106462A IL 106462 A IL106462 A IL 106462A IL 10646293 A IL10646293 A IL 10646293A IL 10646293 A IL10646293 A IL 10646293A IL 106462 A IL106462 A IL 106462A
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- phenylimidazolidine
- derivatives
- Prior art date
Links
- TVPNGVPSNXPYLT-UHFFFAOYSA-N 1-phenylimidazolidine Chemical class C1NCCN1C1=CC=CC=C1 TVPNGVPSNXPYLT-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/40—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4224414A DE4224414A1 (de) | 1992-07-24 | 1992-07-24 | Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL106462A0 IL106462A0 (en) | 1993-11-15 |
| IL106462A true IL106462A (en) | 1997-02-18 |
Family
ID=6463969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10646293A IL106462A (en) | 1992-07-24 | 1993-07-23 | Phenylimidazolidine derivatives their preparation and pharmaceutical compositions containing them |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5424293A (cs) |
| EP (1) | EP0580008B1 (cs) |
| JP (1) | JP3775808B2 (cs) |
| KR (1) | KR100418321B1 (cs) |
| AT (1) | ATE168116T1 (cs) |
| AU (1) | AU664630B2 (cs) |
| CA (1) | CA2101179C (cs) |
| CZ (1) | CZ289297B6 (cs) |
| DE (2) | DE4224414A1 (cs) |
| DK (1) | DK0580008T3 (cs) |
| ES (1) | ES2119837T3 (cs) |
| HU (1) | HU220767B1 (cs) |
| IL (1) | IL106462A (cs) |
| SK (1) | SK282517B6 (cs) |
| TW (1) | TW306918B (cs) |
| ZA (1) | ZA935341B (cs) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4308034A1 (de) * | 1993-03-13 | 1994-09-15 | Cassella Ag | Neue Heterocyclen, ihre Herstellung und ihre Verwendung |
| DE4427979A1 (de) | 1993-11-15 | 1996-02-15 | Cassella Ag | Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung |
| US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
| US5563158A (en) * | 1993-12-28 | 1996-10-08 | The Dupont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
| ZA963391B (en) * | 1995-05-24 | 1997-10-29 | Du Pont Merck Pharma | Isoxazoline fibrinogen receptor antagonists. |
| ATE212990T1 (de) * | 1996-03-20 | 2002-02-15 | Hoechst Ag | Inhibitoren der knochenresorption und vitronectinrezeptor-antagonisten |
| DE19622489A1 (de) | 1996-06-05 | 1997-12-11 | Hoechst Ag | Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters |
| PL323130A1 (en) * | 1996-11-15 | 1998-05-25 | Hoechst Ag | Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such |
| DE19647381A1 (de) * | 1996-11-15 | 1998-05-20 | Hoechst Ag | Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
| DE19647380A1 (de) * | 1996-11-15 | 1998-05-20 | Hoechst Ag | 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
| DE19741235A1 (de) * | 1997-09-18 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| DE19741873A1 (de) * | 1997-09-23 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| DE19751251A1 (de) * | 1997-11-19 | 1999-05-20 | Hoechst Marion Roussel De Gmbh | Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate |
| DE19821483A1 (de) | 1998-05-14 | 1999-11-18 | Hoechst Marion Roussel De Gmbh | Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| US6163155A (en) * | 1999-01-28 | 2000-12-19 | Dresser Industries, Inc. | Electromagnetic wave resistivity tool having a tilted antenna for determining the horizontal and vertical resistivities and relative dip angle in anisotropic earth formations |
| DE19922462A1 (de) | 1999-05-17 | 2000-11-23 | Aventis Pharma Gmbh | Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| AU5625900A (en) * | 1999-06-17 | 2001-01-09 | Cortech, Inc. | Method and compounds for inhibiting activity of serine elastases |
| DE10111877A1 (de) | 2001-03-10 | 2002-09-12 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| DE10137595A1 (de) * | 2001-08-01 | 2003-02-13 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung |
| KR20090055553A (ko) * | 2006-07-11 | 2009-06-02 | 핼리버튼 에너지 서비시즈 인코퍼레이티드 | 모듈화된 지오스티어링 툴 조립체 |
| BRPI0713267B1 (pt) * | 2006-07-12 | 2018-06-19 | Halliburton Energy Services, Inc. | “método para construir uma antena inclinada sobre um segmento recuperável de uma ferramenta de registro durante perfuração, ferramenta de registro durante perfuração, e, ferramenta de furo abaixo recuperável” |
| US8085050B2 (en) * | 2007-03-16 | 2011-12-27 | Halliburton Energy Services, Inc. | Robust inversion systems and methods for azimuthally sensitive resistivity logging tools |
| AU2008365630B2 (en) | 2008-12-16 | 2012-05-03 | Halliburton Energy Services, Inc. | Azimuthal at-bit resistivity and geosteering methods and systems |
| GB2486759B (en) | 2010-01-22 | 2014-09-03 | Halliburton Energy Serv Inc | Method and apparatus for resistivity measurements |
| MX342269B (es) | 2012-06-25 | 2016-09-22 | Halliburton Energy Services Inc | Sistemas y metodos de registro de antena inclinada que producen señales de medicion robustas. |
| EP3286172B1 (en) | 2015-04-23 | 2019-06-12 | Constellation Pharmaceuticals, Inc. | Lsd1 inhibitors and uses thereof |
| US10517849B2 (en) | 2016-10-26 | 2019-12-31 | Constellation Pharmaceuticals, Inc. | LSD1 inhibitors and medical uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4126277A1 (de) * | 1991-08-08 | 1993-02-11 | Cassella Ag | Hydantoinderivate |
| DE4213634A1 (de) * | 1992-04-24 | 1993-10-28 | Cassella Ag | 2,4-Dioxo-imidazolidin-Derivate |
-
1992
- 1992-07-24 DE DE4224414A patent/DE4224414A1/de not_active Withdrawn
-
1993
- 1993-07-01 JP JP16304293A patent/JP3775808B2/ja not_active Expired - Fee Related
- 1993-07-06 ES ES93110754T patent/ES2119837T3/es not_active Expired - Lifetime
- 1993-07-06 DE DE59308732T patent/DE59308732D1/de not_active Expired - Lifetime
- 1993-07-06 AT AT93110754T patent/ATE168116T1/de not_active IP Right Cessation
- 1993-07-06 DK DK93110754T patent/DK0580008T3/da active
- 1993-07-06 EP EP93110754A patent/EP0580008B1/de not_active Expired - Lifetime
- 1993-07-21 CZ CZ19931475A patent/CZ289297B6/cs not_active IP Right Cessation
- 1993-07-21 SK SK769-93A patent/SK282517B6/sk unknown
- 1993-07-22 US US08/095,905 patent/US5424293A/en not_active Expired - Lifetime
- 1993-07-23 ZA ZA935341A patent/ZA935341B/xx unknown
- 1993-07-23 KR KR1019930013987A patent/KR100418321B1/ko not_active Expired - Fee Related
- 1993-07-23 IL IL10646293A patent/IL106462A/xx not_active IP Right Cessation
- 1993-07-23 CA CA002101179A patent/CA2101179C/en not_active Expired - Fee Related
- 1993-07-23 AU AU42119/93A patent/AU664630B2/en not_active Ceased
- 1993-07-23 HU HU9302138A patent/HU220767B1/hu not_active IP Right Cessation
- 1993-07-24 TW TW082105953A patent/TW306918B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| AU664630B2 (en) | 1995-11-23 |
| SK282517B6 (sk) | 2002-10-08 |
| ATE168116T1 (de) | 1998-07-15 |
| CA2101179C (en) | 2003-10-28 |
| JPH0725855A (ja) | 1995-01-27 |
| DE4224414A1 (de) | 1994-01-27 |
| DK0580008T3 (da) | 1999-02-08 |
| DE59308732D1 (de) | 1998-08-13 |
| HU220767B1 (hu) | 2002-05-28 |
| TW306918B (cs) | 1997-06-01 |
| HU9302138D0 (en) | 1993-10-28 |
| EP0580008A2 (de) | 1994-01-26 |
| CA2101179A1 (en) | 1994-01-25 |
| CZ289297B6 (cs) | 2001-12-12 |
| US5424293A (en) | 1995-06-13 |
| IL106462A0 (en) | 1993-11-15 |
| EP0580008A3 (de) | 1995-03-15 |
| AU4211993A (en) | 1994-01-27 |
| EP0580008B1 (de) | 1998-07-08 |
| ES2119837T3 (es) | 1998-10-16 |
| HUT65141A (en) | 1994-04-28 |
| KR940005583A (ko) | 1994-03-21 |
| KR100418321B1 (ko) | 2004-05-07 |
| JP3775808B2 (ja) | 2006-05-17 |
| SK76993A3 (en) | 1994-04-06 |
| ZA935341B (en) | 1994-02-14 |
| CZ147593A3 (en) | 1994-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL106462A0 (en) | Phenylimidazolidine derivatives,their preparation and pharmaceutical compositions containing them | |
| BG100951A (en) | Novel erythromycin derivatives, method for their preparation and their use as drugs | |
| ZW12388A1 (en) | Immunomodulatory azaspiranes | |
| NZ236589A (en) | A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions | |
| IL75337A0 (en) | Quinone derivative,process for the preparation thereof and pharmaceutical compositions containing the same | |
| AU4443689A (en) | Novel-3-piperidinyl-1,2-benzisoxazoles | |
| IL103875A0 (en) | Piperazinyl-and piperidinyl-cyclohexanol derivatives and pharmaceutical compositions containing the same | |
| ZA926328B (en) | Naphthylethylureas and naphthylethylthioureas process for the preparation thereof and pharmaceutical compositions containing them. | |
| HUT55002A (en) | Process for producing pyrimidine -4,6-dicarboxylic acid-diamides and pharmaceutical compositions containing them as active components | |
| TW248559B (cs) | ||
| HUT53664A (en) | Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| IL85992A0 (en) | Dihydropyridinamides,their preparation and pharmaceutical compositions containing them | |
| AU576386B2 (en) | 1h-indol-3-yl containing 1,3-dimethyl-1h-purine-2,6-diones | |
| ZA912618B (en) | 3-aminochroman derivatives,process for preparing these and pharmaceutical compositions containing them | |
| AU579869B2 (en) | 4-amino-8-alkylthio-2-piperazino-pyrimido ``5,4-d`` pyrimidines | |
| IL85658A (en) | Pharmaceutical compositions containing substituted pyridine-2,4-dicarboxylic acid derivatives,some such compounds and processes for their preparation | |
| HUT50142A (en) | Process for producing allyl-mercapto-acetyl-sidnonimine derivatives and pharmaceutical compositions containing them | |
| IL108856A0 (en) | Hydroxymethyl-furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| HUT54653A (en) | Process for producing n,n'-bis(alkoxyalkyl)-pyridine-2,4-dicarboxylic acid diamide derivatives and pharmaceutical compositions comprising such compounds | |
| PL314794A1 (en) | Crystalline polymorphous form of (s,s,s)-n-(1-[2-carbocy-3-(n2-mezilolysilamino)propyl]-1-cyclopentylocabonyl)thyrosine | |
| ZA941196B (en) | Angiopeptin cyclopeptide compounds process for the preparation thereof and pharmaceutical compositions containing them | |
| HUT73562A (en) | Thiocarbamoyl-pyrazole derivatives, keto-carboxylic acid ester intermediates thereof, preparations thereof, using the pyrazole derivatives and microbicide compositions containing these compounds | |
| IL104444A0 (en) | Alpha-aryl-alpha-hydroxy-beta-imidazolinyl-propionamides,their preparation and pharmaceutical compositions containing them | |
| HU901631D0 (en) | Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |